- Article metrics
- Last updated: Tue, 20 May 2025 14:14:31 Z
Cost-effectiveness of nirsevimab and maternal RSVpreF for preventing respiratory syncytial virus disease in infants across Canada
Access & Citations
-
- 1355
- Article Accesses
-
- Data not available
- Web of Science
-
- Data not available
- CrossRef
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.